Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-26-000075
Filing Date
2026-02-09
Accepted
2026-02-09 18:08:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10058
2 exhibit99.htm EX-99 4449
  Complete submission text file 0000935836-26-000075.txt   16560
Mailing Address 394 PACIFIC AVENUE FLOOR 4 SAN FRANCISCO CA 94111
Business Address 394 PACIFIC AVENUE FLOOR 4 SAN FRANCISCO CA 94111 415-659-7226
Valiant Capital Management, L.P. (Filed by) CIK: 0001452689 (see all company filings)

EIN.: 262303018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904
Business Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904 (425) 998-5300
Core Scientific, Inc./tx (Subject) CIK: 0001839341 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92274 | Film No.: 26612823
SIC: 6199 Finance Services
(CF Office: 09 Crypto Assets)